TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Corline Biomedical AB
Closing information (x1000 NOK)
| Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
| Turnover |
22,276
|
6,887
|
3,872 |
| Financial expenses |
0
|
13
|
0 |
| Earnings before taxes |
2,203
|
-6,750
|
-7,634 |
| EBITDA |
2,256
|
-6,708
|
-7,619 |
| Total assets |
96,278
|
99,142
|
61,056 |
| Current assets |
34,051
|
43,708
|
11,249 |
| Current liabilities |
6,805
|
9,193
|
6,548 |
| Equity capital |
89,473
|
89,949
|
54,509 |
| - share capital |
2,541
|
2,619
|
2,183 |
| Employees (average) |
10
|
9
|
8 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
| Solvency |
92.9%
|
90.7%
|
89.3% |
| Turnover per employee |
2,228
|
765
|
484 |
| Profit as a percentage of turnover |
9.9%
|
-98.0%
|
-197.2% |
| Return on assets (ROA) |
2.3%
|
-6.8%
|
-12.5% |
| Current ratio |
500.4%
|
475.4%
|
171.8% |
| Return on equity (ROE) |
2.5%
|
-7.5%
|
-14.0% |
| Change turnover |
15,596
|
3,283
|
2,757 |
| Change turnover % | 233% | 247% | |
| Chg. No. of employees |
1
|
1
|
-1 |
| Chg. No. of employees % | 11% | -11% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.